Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Medical Research Laboratories International |
---|---|
Information provided by: | Medical Research Laboratories International |
ClinicalTrials.gov Identifier: | NCT00080132 |
The purpose of this study is to determine if implitapide is effective in lowering triglyceride (TG) levels in patients with Fredrickson Type I or V hypertriglyceridemia where the maximum tolerable medication and diet were not sufficient.
Condition | Intervention | Phase |
---|---|---|
Hypertriglyceridemia |
Drug: implitapide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Safety/Efficacy Study |
Official Title: | An Open-Label, Dose-Escalating Efficacy and Safety Study of Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy |
Ages Eligible for Study: | 8 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
In order to participate in this study, patients must meet all of the following inclusion criteria:
Exclusion Criteria:
United States, Ohio | |
Metabolic and Atherosclerosis Research Center | |
Cincinnati, Ohio, United States, 45229 | |
United States, Texas | |
The Methodist Hospital | |
Houston, Texas, United States, 77030 | |
Netherlands | |
Andromed Noord | |
Groningen, Netherlands, 9711 SG | |
Andromed Oost | |
Velp, Netherlands, 6883 HM | |
Andromed Rotterdam | |
Rotterdam, Netherlands, 3021 HC | |
Andromed Leiden | |
Leiden, Netherlands, 2311 GZ | |
Andromed Zoetermeer | |
Zoetermeer, Netherlands, 2724 EK | |
Academic Medical Center Amsterdam | |
Amsterdam, Netherlands, 1105 AZ | |
Norway | |
Lipidklinikken - Rikshospitalet | |
Oslo, Norway |
Study ID Numbers: | MRL 2002-003 |
Study First Received: | March 23, 2004 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00080132 |
Health Authority: | United States: Food and Drug Administration |
HTG Hypertriglyceridemia, Fredrickson Type I Hypertriglyceridemia, Fredrickson Type V |
Metabolic Diseases Hyperlipidemias Hypertriglyceridemia |
Metabolic disorder Dyslipidemias Lipid Metabolism Disorders |